Should Off-Label Drugs Be Included as Comparators in Pharmacoeconomic Studies?
Crossref DOI link: https://doi.org/10.1007/s40273-014-0222-2
Published Online: 2014-10-01
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Walton, Surrey M.
Schumock, Glen T.
Text and Data Mining valid from 2014-10-01